Skip to Content

Ethyl Loflazepate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05BA18

CAS registry number (Chemical Abstracts Service)

0029177-84-2

Chemical Formula

C18-H14-Cl-F-N2-O3

Molecular Weight

360

Therapeutic Category

Anxiolytic agent

Chemical Name

1H-1,4-Benzodiazepin-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, etyl ester

Foreign Names

  • Ethylis loflazepas (Latin)
  • Ethyl loflazepat (German)
  • Loflazépate d'éthyle (French)
  • Loflazepato de etilo (Spanish)

Generic Names

Brand Names

  • Demethox
    Nichi-Iko Pharmaceutical, Japan
  • Ethyl Loflazepate Sawai
    Sawai Seiyaku, Japan
  • Ethyl Loflazepate Towa
    Towa Yakuhin, Japan
  • Meilax
    Meiji, China; Meiji Seika Pharma, Japan
  • Meilax 1%
    Meiji Seika Pharma, Japan
  • Ronlax
    Shiono Kemikaru, Japan
  • Sukarnase
    Towa Yakuhin, Japan
  • Victan
    Sanofi, Dominican Republic; Sanofi, Guatemala; Sanofi, Panama; Sanofi Belgium, Belgium; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, France; Sanofi-Aventis, Honduras; Sanofi-Aventis, Mexico; Sanofi-Aventis, Portugal; Sanofi-Aventis, El Salvador; Sintofarm, Romania

International Drug Name Search

Glossary

TermDefinition
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide